Kobayashi Osamu, Sugiyama Yuka, Konishi Kazuo, Kanari Masahiro, Cho Haruhiko, Tsuburaya Akira, Sairenji Motonori, Motohashi Hisahiko, Yoshikawa Takaki
Dept. of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City University.
Gan To Kagaku Ryoho. 2002 Oct;29(10):1753-8.
We compared the clinicopathological factors and treatment results with regard to symptoms and screening in patients who underwent gastrectomy for primary gastric cancer.
The subjects included 797 patients with asymptomatic gastric cancer (SCG) and 1090 patients with symptomatic cancer (SYG) who had undergone gastrectomy for gastric cancer from 1989 to 2000.
The proportion of early gastric cancer, N0 cases, and curative cases in the SCG and SYG patients were 70% & 33%, 77% & 44%, and 98% & 80%, respectively (p = 0.000, for each). Five-year survival rates of the SCG and SYG patients were 87% and 63% (p = 0.000).
Screening for gastric cancer in order to detect asymptomatic disease may contribute to patient survival.
我们比较了因原发性胃癌接受胃切除术患者的临床病理因素以及症状和筛查方面的治疗结果。
研究对象包括1989年至2000年期间因胃癌接受胃切除术的797例无症状胃癌患者（SCG）和1090例有症状癌症患者（SYG）。
SCG和SYG患者中早期胃癌、N0病例和治愈病例的比例分别为70%和33%、77%和44%、98%和80%（每项p = 0.000）。SCG和SYG患者的五年生存率分别为87%和63%（p = 0.000）。
为检测无症状疾病而进行的胃癌筛查可能有助于提高患者生存率。
